These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 38294332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin.
    Kim JY, Ilham S, Alshannaq H, Pollock RF, Ahmed W, Norman GJ, Jin SM, Kim JH.
    J Med Econ; 2024; 27(1):1245-1252. PubMed ID: 39275990
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark.
    Alshannaq H, Cogswell G, Pollock RF, Ahmed W, Norman GJ, Lynch PM, Roze S.
    Diabetes Obes Metab; 2023 Sep; 25(9):2704-2713. PubMed ID: 37334522
    [Abstract] [Full Text] [Related]

  • 6. Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective.
    Del Prato S, Giorgino F, Szafranski K, Poon Y.
    Diabetes Obes Metab; 2024 Sep; 26(9):3633-3641. PubMed ID: 38853717
    [Abstract] [Full Text] [Related]

  • 7. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S, Isitt J, Smith-Palmer J, Javanbakht M, Lynch P.
    Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
    [Abstract] [Full Text] [Related]

  • 8. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia.
    Isitt JJ, Roze S, Tilden D, Arora N, Palmer AJ, Jones T, Rentoul D, Lynch P.
    Diabet Med; 2022 Jul; 39(7):e14831. PubMed ID: 35298036
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada.
    Roze S, Isitt JJ, Smith-Palmer J, Lynch P.
    Clinicoecon Outcomes Res; 2021 Jul; 13():717-725. PubMed ID: 34408456
    [Abstract] [Full Text] [Related]

  • 14. Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France.
    Roze S, Smith-Palmer J, Valentine W, Payet V, de Portu S, Papo N, Cucherat M, Hanaire H.
    Diabetes Technol Ther; 2016 Feb; 18(2):75-84. PubMed ID: 26646072
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L.
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran.
    Molaee MC, Naseri ZG, Karami MA.
    Value Health Reg Issues; 2024 Sep; 43():101002. PubMed ID: 38820700
    [Abstract] [Full Text] [Related]

  • 20. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
    Jendle J, Buompensiere MI, Ozdemir Saltik AZ, de Portu S, Smith-Palmer J, Pollock RF, Cohen O.
    Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.